ImmunoGen, Inc. (IMGN): Price and Financial Metrics

IMGN POWR Grades

• Value is the dimension where IMGN ranks best; there it ranks ahead of 59.03% of US stocks.
• The strongest trend for IMGN is in Stability, which has been heading down over the past 179 days.
• IMGN ranks lowest in Momentum; there it ranks in the 4th percentile.

IMGN Stock Summary

• Of note is the ratio of ImmunoGen Inc's sales and general administrative expense to its total operating expenses; merely 9.45% of US stocks have a lower such ratio.
• IMGN's price/sales ratio is 15.34; that's higher than the P/S ratio of 90.77% of US stocks.
• As for revenue growth, note that IMGN's revenue has grown -47.2% over the past 12 months; that beats the revenue growth of only 3.45% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ImmunoGen Inc are MGNX, ATHX, JNCE, CLLS, and LPTX.
• IMGN's SEC filings can be seen here. And to visit ImmunoGen Inc's official web site, go to www.immunogen.com.

IMGN Valuation Summary

• In comparison to the median Healthcare stock, IMGN's price/earnings ratio is 160% lower, now standing at -21.9.
• IMGN's price/earnings ratio has moved up 60.5 over the prior 243 months.
• IMGN's EV/EBIT ratio has moved up 60 over the prior 243 months.

Below are key valuation metrics over time for IMGN.

IMGN Growth Metrics

The 3 year cash and equivalents growth rate now stands at 47.83%.
• Its 2 year price growth rate is now at -59.17%.
• Its 5 year revenue growth rate is now at 33.39%.

IMGN's revenue has moved down $21,509,000 over the prior 15 months.

The table below shows IMGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	69.856	-169.416	-139.303
2021-09-30	127.662	-115.007	-70.743
2021-06-30	136.641	-110.612	-55.778
2021-03-31	134.718	-94.926	-49.335
2020-12-31	132.299	-78.62	-44.372
2020-09-30	91.365	-119.712	-70.946

IMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IMGN has a Quality Grade of C, ranking ahead of 34.67% of graded US stocks.
• IMGN's asset turnover comes in at 0.393 -- ranking 121st of 682 Pharmaceutical Products stocks.
• TARO, HTBX, and ENTA are the stocks whose asset turnover ratios are most correlated with IMGN.

The table below shows IMGN's key quality metrics over time.